Hironaka S - Search Results

1

Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1.

Oshima K, Kato K, Ito Y, Daiko H, Nozaki I, Nakagawa S, Shibuya Y, Kojima T, Toh Y, Okada M, Hironaka S, Akiyama Y, Komatsu Y, Maejima K, Nakagawa H, Onuki R, Nagai M, Kato M, Kanato K, Kuchiba A, Nakamura K, Kitagawa Y. Oshima K, et al. Among authors: hironaka s. Cancer Sci. 2022 Mar;113(3):1018-1027. doi: 10.1111/cas.15251. Epub 2022 Jan 10. Cancer Sci. 2022. PMID: 34962019 Free PMC article. Clinical Trial.

2

Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy.

Hironaka S, Hasebe T, Kamijo T, Ohtsu A, Boku N, Yoshida S, Saitoh H, Ochiai A. Hironaka S, et al. Clin Cancer Res. 2002 Jan;8(1):124-30. Clin Cancer Res. 2002. PMID: 11801548

3

Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.

Muto M, Hironaka S, Nakane M, Boku N, Ohtsu A, Yoshida S. Muto M, et al. Among authors: hironaka s. Gastrointest Endosc. 2002 Oct;56(4):517-21. doi: 10.1067/mge.2002.128104. Gastrointest Endosc. 2002. PMID: 12297767

4

Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus.

Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S, Ogino T, Yamamoto S, Ochiai A. Hironaka S, et al. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):425-33. doi: 10.1016/s0360-3016(03)00585-6. Int J Radiat Oncol Biol Phys. 2003. PMID: 12957254

5

A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.

Nakajima TE, Ura T, Ito Y, Kato K, Minashi K, Nihei K, Hironaka S, Boku N, Kagami Y, Muro K. Nakajima TE, et al. Among authors: hironaka s. Jpn J Clin Oncol. 2009 Jan;39(1):37-42. doi: 10.1093/jjco/hyn125. Jpn J Clin Oncol. 2009. PMID: 19103671 Clinical Trial.

6

Efficacy of sequential methotrexate and 5-fluorouracil (MTX/5FU) in improving oral intake in patients with advanced gastric cancer with severe peritoneal dissemination.

Imazawa M, Kojima T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yasui H, Yamazaki K, Taku K. Imazawa M, et al. Among authors: hironaka s. Gastric Cancer. 2009;12(3):153-7. doi: 10.1007/s10120-009-0517-8. Epub 2009 Nov 5. Gastric Cancer. 2009. PMID: 19890695

7

Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatin.

Shimoyama R, Yasui H, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamazaki K, Taku K, Kojima T, Machida N, Todaka A, Tomita H, Sakamoto T, Tsushima T. Shimoyama R, et al. Among authors: hironaka s. Gastric Cancer. 2009;12(4):206-11. doi: 10.1007/s10120-009-0524-9. Epub 2010 Jan 5. Gastric Cancer. 2009. PMID: 20047125

8

A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy.

Kato K, Tahara M, Hironaka S, Muro K, Takiuchi H, Hamamoto Y, Imamoto H, Amano N, Seriu T. Kato K, et al. Among authors: hironaka s. Cancer Chemother Pharmacol. 2011 Jun;67(6):1265-72. doi: 10.1007/s00280-010-1422-x. Epub 2010 Aug 12. Cancer Chemother Pharmacol. 2011. PMID: 20703479 Clinical Trial.

9

Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.

Kato K, Nakajima TE, Ito Y, Katada C, Ishiyama H, Tokunaga SY, Tanaka M, Hironaka S, Hashimoto T, Ura T, Kodaira T, Yoshimura K. Kato K, et al. Among authors: hironaka s. Jpn J Clin Oncol. 2013 Jun;43(6):608-15. doi: 10.1093/jjco/hyt048. Epub 2013 Apr 12. Jpn J Clin Oncol. 2013. PMID: 23585687 Clinical Trial.

10

Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study).

Nakamura K, Kato K, Igaki H, Ito Y, Mizusawa J, Ando N, Udagawa H, Tsubosa Y, Daiko H, Hironaka S, Fukuda H, Kitagawa Y; Japan Esophageal Oncology Group/Japan Clinical Oncology Group. Nakamura K, et al. Among authors: hironaka s. Jpn J Clin Oncol. 2013 Jul;43(7):752-5. doi: 10.1093/jjco/hyt061. Epub 2013 Apr 26. Jpn J Clin Oncol. 2013. PMID: 23625063 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters